Estroven Review (2026): Which Box Actually Works, and What's Inside It

Disclosure: We have no financial relationship with Estroven, i-Health, Inc., or dsm-firmenich. Some provider links reached through our care-routing pages may be affiliate links; see our full disclosure. That does not affect this review.

Estroven review: the short answer

This Estroven review found eight current oral formulas, and they are not interchangeable. Three Complete products use 4 mg of rhapontic rhubarb; five targeted products use black cohosh plus soy. The Menopause Society recommends none of those ingredients for hot flashes. Our normalized 60-serving cost runs from $24.99 to $56.97.^[1][13]

Is Estroven a reasonable try for you?

Best for:

• Your hot flashes or night sweats are mild enough that you are comfortable trying an over-the-counter supplement first.
• You have already decided against hormone therapy for your own reasons, or you are not ready for a prescription conversation yet.
• You have checked the exact formula against your health history, allergies, medications, and other supplements.
• You are willing to pick one box, track one symptom, and set a stop date before day one.
• You can spend $24.99 to $56.97 for 60 or more daily servings without letting sunk cost keep you on a product that is doing nothing.

Not for you if:

• Your symptoms are severe, soak the bed most nights, or affect work, concentration, or driving.
• You have bleeding after menopause or a sudden, unexplained change in bleeding.
• You have liver disease, abnormal liver tests, or take medication that can affect the liver.
• You have had breast cancer, uterine cancer, or another hormone-sensitive condition and have not cleared the ingredients with your care team.
• You have a soy allergy and are considering one of the five black-cohosh-and-soy formulas.
• You take a blood thinner, antiplatelet, sedative, thyroid medication, immunosuppressant, seizure medication, or several medicines that make interactions hard to judge.
• You are buying it as a substitute for targeted care for painful sex, vaginal dryness, recurrent urinary infections, or bladder symptoms.

Your situation	Our answer	Why
You are set on trying one Estroven product	Complete Multi-Symptom, 60 caplets — $29.99	One botanical extract at the studied 4 mg dose, soy-free, caffeine-free, and $0.50 per serving. It is the cleanest Estroven-specific trial, not a guideline-backed first-line treatment.
You cannot swallow caplets	Complete Gummies — $26.48 for 30	The published active dose is also 4 mg, but obtaining 60 servings costs $52.96—$22.97 more than the 60-count caplets.
Night sweats are waking you	Sleep Cool may fit the symptom, but it is also a melatonin decision	It contains 2 mg melatonin plus black cohosh and soy. Do not treat it as “Complete at bedtime.”
You are hoping the Weight Management box will produce proven weight loss	Do not buy it on that assumption	Its published active panel matches Pre-Menopause exactly, and its CQR-300 evidence is not menopause-specific.
You are caffeine-sensitive or sleep is already fragile	Avoid Stress Relief & Energy Boost	The manufacturer lists 52 mg of caffeine per daily serving.
Your symptoms are severe or nothing over the counter has helped	Skip the aisle and start with a clinician	Hormone therapy remains the most effective treatment for vasomotor symptoms for appropriate candidates, with evidence-based nonhormonal prescription and nondrug options available too.[13]

The key timing and cost distinction

Estroven does not give all eight formulas the same timing claim. The three Complete formulas say results may appear in as little as 28 days. The five targeted black-cohosh-and-soy formulas say to use them daily for a minimum of 60 days.^{[2][3][4][5][6][7][8][9]}

The $24.99 to $56.97 number on this page is our apples-to-apples cost of obtaining at least 60 daily servings. It is a comparison metric—not a claim that Estroven tells every customer to run every formula for 60 days.

Box prices look simpler: $13.99 to $34.99 at current one-time manufacturer prices. That range hides the pack-count problem. One formula comes in 28-count boxes even though its page calls it a “30 Day Supply” and tells users to allow at least 60 days. Two boxes leave you four doses short.^[7]

How did we verify this Estroven review?

We did a documentation and label review, not a hands-on product test. On September 2, 2026, we opened every current Estroven product page, transcribed the published Supplement Facts panels, recorded pack sizes and one-time prices, checked the brand's timing claims, subscription terms, shipping threshold, return policy, and product FAQs, and compared them in one normalized dataset.^[1][11][12]

We then read the 2023 Nonhormone Therapy Position Statement of The North American Menopause Society, the pivotal ERr 731 randomized trial, newer ERr 731 research published through June 2026, federal dietary-supplement guidance, NIH safety resources, and the July 2026 federal complaint involving two Estroven formulas.^{[13][14][16][17][27][33][34]}

We did not purchase, swallow, laboratory-test, or commission-test any product. We did not verify the full inactive-ingredient and manufacturing specification of every formula. Where two products publish the same active panel, we say exactly that—we do not call the finished products identical.

The HRT Index is the independent decision resource for online menopause and HRT care — comparing telehealth providers on clinical legitimacy, care quality, medication fit, price transparency, and access, with every claim verified and dated, so women can choose the path that fits their situation before their first consult.

Which Estroven should you buy?

Within the Estroven line, Complete Multi-Symptom in the 60-count is the most defensible starting point for a suitable reader who has already decided to try the brand. It has the clearest ingredient-level research, no soy or caffeine, and a $29.99 price for 60 servings. The Menopause Society still does not recommend rhapontic rhubarb for hot flashes.^[2][13]

That is a judgment about which Estroven box is easiest to evaluate cleanly. It is not a claim that Estroven is the best menopause treatment overall.

If you are…	What we would choose inside Estroven	The trade-off you need to accept
Set on trying the brand and want the simplest formula	Complete Multi-Symptom caplets, 60 count	The ingredient has positive trials, but the 2023 society panel found the evidence too limited to recommend it.
Unable to swallow caplets	Complete Gummies	Same published 4 mg ERr 731 dose, but 60 servings cost 77% more and the gummy lists 1 g added sugar per serving.
Mainly trying to sleep through night sweats	Sleep Cool	It adds 2 mg melatonin, so drowsiness, driving, and other sedatives become part of the decision. It also contains soy and black cohosh.
Mainly concerned about mood	Mood Boost only after checking ginkgo interactions	It contains 120 mg ginkgo plus black cohosh, soy, and magnolia bark. A blood thinner or upcoming procedure can change the answer.
Mainly concerned about stress and daytime energy	Stress Relief & Energy Boost only if caffeine fits you	It contains 52 mg caffeine, 80 mg black cohosh, and the most expensive path to the brand's stated 60-day minimum.
Choosing between Pre-Menopause and Weight Management	Do not choose on the front label alone	Both publish black cohosh 40 mg, soy isoflavones 56 mg, and CQR-300 300 mg per serving. We did not verify that every inactive ingredient is identical.
Looking for proven weight loss, treatment for GSM, or prescription-strength symptom control	None of the eight	The product line does not replace evidence-based weight care, targeted vaginal or urinary treatment, or clinician-guided menopause care.

The 60-count Complete caplet wins inside the product line because it strips away several confounders: no melatonin, ginkgo, caffeine, ashwagandha, soy, or Cissus. If you improve, you have a better idea what you tested. If you do not, you have spent $29.99 rather than drifting through several boxes with different active ingredients.

Which Estroven is which? All 8 formulas by what is actually inside

Estroven currently sells eight oral supplements, not one formula in eight packages. Three Complete products publish 4 mg of ERr 731 rhapontic rhubarb and are soy-free. Five targeted formulas publish black cohosh plus soy isoflavones, with melatonin, ginkgo, caffeine-containing botanicals, magnolia bark, or CQR-300 layered on top.^[1]

That split is the single most useful thing to know before you spend a dollar. Two women can both say “I take Estroven” while taking different plants, different doses, and different secondary ingredients.

• ERr 731 / rhapontic rhubarb is a standardized extract of Rheum rhaponticum root. It is not estrogen. Laboratory research on its constituents describes selective estrogen-receptor-beta activity, which is not the same thing as containing estrogen or being equivalent to hormone therapy.^[15]
• Black cohosh is Actaea racemosa. The 2023 Menopause Society statement says its active ingredients and mechanism remain unclear and does not recommend it for vasomotor symptoms.^[13]
• Soy isoflavones are plant compounds with estrogen-receptor activity. Response may differ partly because only a minority of North American women convert daidzein to equol, discussed in the safety section.^[13]

The HRT Index Estroven Formula-to-Evidence Matrix

Verified September 2, 2026. Ingredient amounts were transcribed from the current Supplement Facts panels. Prices are manufacturer one-time prices before tax and shipping. “60-serving spend” is The HRT Index's normalized comparison—not the manufacturer's universal trial recommendation.

Product	Published active ingredients per daily serving	Key flag	Manufacturer's stated timing	Current one-time price and count	Spend to obtain at least 60 servings	2023 Menopause Society finding on the core menopause active
Complete Multi-Symptom caplets	ERr 731 rhapontic rhubarb root extract 4 mg, providing rhaponticin 2.2 mg and desoxyrhaponticin 1 mg	Soy-free; caffeine-free	Results “in as little as 28 days”	28 count $19.99; 60 count $29.99	$29.99 for 60; $0.50/serving	Rhapontic rhubarb: Level II, not recommended
Complete Menopause Relief Gummies	ERr 731 rhapontic rhubarb root extract 4 mg; label lists 1 g added sugar	Gummy form; soy-free	Results “in as little as 28 days”	30 count $26.48	$52.96 for 60; $0.88/serving	Same rhapontic-rhubarb finding
Complete + Ashwagandha	Magnesium 50 mg; ERr 731 4 mg; Sensoril ashwagandha root-and-leaf extract 125 mg	Adds thyroid, autoimmune, pregnancy, sedation, blood-pressure, blood-sugar, and interaction questions	Results “in as little as 28 days”	60 count $34.99	$34.99 for 60; $0.58/serving	Rhapontic rhubarb not recommended; ashwagandha not assessed in this statement
Sleep Cool	Calcium 112 mg; black cohosh 40 mg; soy isoflavones 56 mg; melatonin 2 mg	Soy; bedtime sedation; manufacturer says not to drive or operate machinery after taking	Minimum 60 days	30 count $13.99; 60 count $24.99	$24.99 for 60; $0.42/serving	Black cohosh: Level I, not recommended; soy extracts: Level II, not recommended
Mood Boost	Calcium 95 mg; black cohosh 40 mg; soy isoflavones 56 mg; ginkgo 120 mg; magnolia bark 15 mg	Soy; ginkgo interaction and bleeding questions; named in July 2026 complaint	Minimum 60 days	30 count $13.99; 60 count $24.99	$24.99 for 60; $0.42/serving	Black cohosh and soy not recommended
Stress Relief & Energy Boost	Calcium 90 mg; black cohosh 80 mg; soy isoflavones 60 mg; green tea extract 100 mg; yerba maté 30 mg; magnolia bark 15 mg	52 mg caffeine; twice the black-cohosh dose of the other targeted formulas; named in July 2026 complaint	Minimum 60 days	28 count $18.99; page also calls it a “30 Day Supply”	$56.97 for 84; $0.68/serving	Black cohosh and soy not recommended
Pre-Menopause	Black cohosh 40 mg; soy isoflavones 56 mg; CQR-300 Cissus quadrangularis 300 mg	Soy; same published active panel and doses as Weight Management	Minimum 60 days	30 count $18.99; 60 count $34.99	$34.99 for 60; $0.58/serving	Black cohosh and soy not recommended; CQR-300 not assessed in this statement
Weight Management	Black cohosh 40 mg; soy isoflavones 56 mg; CQR-300 Cissus quadrangularis 300 mg	Soy; same published active panel and doses as Pre-Menopause	Minimum 60 days	30 count $18.99; 60 count $34.99	$34.99 for 60; $0.58/serving	Black cohosh and soy not recommended; CQR-300 not assessed in this statement

Four label findings worth stopping on

1. Pre-Menopause and Weight Management publish the same active panel. Both list black cohosh 40 mg, soy isoflavones 56 mg, and CQR-300 300 mg. That does not prove their inactive ingredients, tablet coatings, or manufacturing specifications are identical. It does mean the front-of-box positioning is doing more differentiation than the published active doses.

2. Stress Relief & Energy Boost needs three boxes to clear 60 servings. One 28-count box is not 30 doses. Two boxes are 56. At the current one-time price, the smallest purchase that reaches the brand's stated 60-day minimum is three boxes: $56.97 for 84 servings.

3. The gummy charges a real form premium. Sixty gummy servings cost $52.96 versus $29.99 for 60 caplets. That is $22.97 more, or about 77%, for a different delivery form. If swallowing caplets is a real barrier, the premium has a purpose. If it is not, it is expensive flavor and texture.

4. The Menopause Stage Indicator is not a ninth formula. Estroven's collection page labels the at-home FSH test “Coming Soon,” while its product page is unavailable and tagged as discontinued. The page describes five urine test sticks used over at least nine days and says the result should be confirmed by a physician. Treat that as a website-status inconsistency, not current diagnostic availability.^[10]

Can you combine two Estroven formulas?

Do not build your own stack from the product names. Estroven's Sleep Cool FAQ tells customers not to combine Sleep Cool with a daytime Estroven product and says the products were developed for individual use.^[5]

That matters because doubling up can mean duplicate black cohosh and soy, plus melatonin, ginkgo, caffeine, ashwagandha, or other ingredients that change the interaction question. If one formula does not cover every symptom, that is a reason to choose the dominant symptom or ask a clinician—not a reason to take two boxes on your own.

The right online HRT provider isn't the same for every woman — it depends on your symptoms, your age and whether you have a uterus, your medication route preference (patch, pill, gel, or vaginal estrogen), your risk history, your insurance or cash-pay situation, and your state. Some situations belong with an in-person clinician first. Because a general answer can't resolve those for you, use The HRT Index's Find My HRT Path tool to match your situation to the right provider — and to flag when online care isn't the right starting point — before your first consult.

→ Find the care path that fits my situation · Free · about 90 seconds · no email required

Does Estroven actually work?

The honest answer depends on the formula, and the evidence is weaker than the front of the box makes it feel. The Menopause Society's 2023 panel reviewed rhapontic rhubarb, black cohosh, and soy extracts and recommended none of them for hot flashes. Newer rhubarb analyses are positive, but they do not erase the trial-design problems behind that verdict.^[13][16][17]

What Estroven claims—and what the footnotes actually establish

The current Complete pages use claims including “clinically proven,” “up to 90% reduction,” “#1 menopause brand,” and “#1 pharmacist recommended.” The footnotes matter because those four phrases are not four clinical findings.^[2]

Claim on the product page	What the cited footnote is tied to	What that does—and does not—tell you
“Up to 90% reduction”	A clinical study after 12 weeks of use	It describes the upper end of a study result, not the average outcome every buyer should expect.
Relief across symptoms tested	Menopause Rating Scale II results versus placebo	It tells you which symptom scale was used. It does not make every front-of-box symptom claim equally well proven.
“#1 menopause brand”	Nielsen retail-sales data for the period named in the footnote	It measures sales, not symptom relief.
“#1 pharmacist recommended”	A Pharmacy Times survey	It measures a survey response, not a randomized efficacy comparison.

None of those footnotes is automatically improper. But sales leadership and pharmacist recommendation are not clinical endpoints, and an “up to” number is not the result most women should expect.

The number the front of the box does not show: 7 out of 55

The pivotal randomized trial of ERr 731 enrolled 109 perimenopausal women for 12 weeks. Fifty-five were assigned placebo and 54 were assigned the rhubarb extract.^[14]

The Menopause Society's evidence review highlighted a brutal imbalance at the finish line: only 7 of 55 women in the placebo group completed the trial, compared with 39 of 54 in the ERr 731 group.^[13]

That does not mathematically prove the extract did nothing. It does mean the comparison is vulnerable to serious attrition bias. When the control group loses almost nine of every ten participants—and loses far more than the treatment group—the women who remain may no longer represent the groups that were randomized at the start. The panel concluded that the very low retention rate and the open-label design of another study limited what could be inferred. Its rating: Level II, not recommended.

What newer evidence adds—and what it still cannot answer

A 2024 systematic review and meta-analysis pooled four ERr 731 studies involving 390 participants and reported improvement in Menopause Rating Scale scores. The authors also described potential bias and substantial heterogeneity across the included studies.^[16]

A paper published in June 2026 reported a 12-week randomized phase involving 112 women, followed by a 52-week open-label observational phase involving 89 participants. Symptoms improved during treatment, but everyone in the long-term phase received ERr 731; there was no continuing placebo group. The paper also discloses author relationships with the sponsor or research organization, and its limitations section specifically acknowledges potential sponsorship bias.^[17]

So the current evidence picture is not “nothing works.” It is this:

• There are positive ERr 731 studies.
• The strongest society guidance still finds the evidence too limited to recommend rhapontic rhubarb for vasomotor symptoms.
• The newer long-term paper adds duration, but not an independent long-term placebo comparison.
• None of this tells you in advance whether your own symptoms will change.

The placebo problem is bigger than most supplement reviews admit

The same 2023 statement reports placebo improvement rates of 20% to 66% in trials of treatments for vasomotor symptoms.^[13]

That does not mean a woman who says Estroven helped is imagining it. Her relief can be real. It means an individual story cannot separate the ingredient's effect from expectation, natural symptom fluctuation, regression to the mean, or other changes happening at the same time.

A product can collect thousands of sincere five-star reviews without proving that the formula beats placebo for a typical buyer. That is why the stop rule later on this page matters more than another testimonial.

The damaging admission

Here is the part that does not help anybody sell anything:

The Menopause Society's 2023 expert panel does not recommend the core menopause active in any current Estroven formula. Not black cohosh. Not soy extracts. Not rhapontic rhubarb.

If “clinically proven, right there on the box” was the whole reason you were reaching for it, that reason does not survive contact with the source document.

If guideline-backed effectiveness is your top priority, Estroven is the wrong tool. Hormone therapy remains the most effective treatment for hot flashes and night sweats for women who are appropriate candidates, and there are evidence-based nonhormonal prescription and nondrug options when hormone therapy is not appropriate or not wanted.^[13]

But “not recommended” is not the same as “proven useless.” Complete Multi-Symptom costs $0.50 per serving at the current 60-count price. It is available without an appointment. A suitable adult who understands the limits, clears interactions, chooses one formula, and sets a stop date may still decide that a bounded trial is worth it.

The mistake is not trying one box. The mistake is letting one box turn into months of automatic renewals while the symptom that brought you here keeps running your life.

Because the real cost of a supplement that does nothing is not the first $30. It is the sleep, concentration, sex, and time you keep losing while you wait for certainty the bottle cannot give you.

Going to try it? Run it like a test, not a hope. Use the Estroven Trial Rule below to write down one outcome and one stop decision before day one.

What the same panel does recommend for hot flashes

The 2023 statement recommends the following interventions for vasomotor symptoms:^[13]

• Cognitive behavioral therapy and clinical hypnosis — Level I; nondrug options.
• SSRIs and SNRIs, gabapentin, and fezolinetant — Level I.
• Oxybutynin — Levels I–II.
• Weight loss and stellate ganglion block — Levels II–III.

That list is not a personalized treatment plan, and every medication has its own eligibility and safety questions. The point is simpler: the evidence hierarchy does not end at the supplement shelf. See our current guide to nonhormonal menopause treatment options or use Find My HRT Path when the answer depends on your medical history and access.

How long does Estroven take to work?

Estroven says the three Complete formulas may show results in as little as 28 days, while the five black-cohosh-and-soy formulas need a minimum of 60 days of daily use. Those are manufacturer timing claims, not a guarantee. The most useful move is to measure one symptom before you start so memory does not rewrite the baseline later.^[2][5]

Two months is long enough for the weather to change, a stressful stretch to end, a menstrual cycle to shift, sleep habits to change, and your memory of “how bad it was” to soften. By day 60, “I think it might be a little better” is almost impossible to interpret.

So do not ask a vague question. Ask a numbered one.

The Estroven Trial Rule

Step 1 — Confirm the exact box. Photograph the front and Supplement Facts panel. Write down the formula, serving size, start date, active ingredients, and the manufacturer's timing claim. “Estroven” alone is not enough.

Step 2 — Run the safety check before the first dose. Compare the exact panel against allergies, health conditions, medications, and other supplements. Bring the box—not just the brand name—to a pharmacist or prescriber when interactions are not obvious.

Step 3 — Pick one outcome. Hot flashes per day. Nights awakened per week. Drenched-sheet episodes. One number tied to the symptom that is costing you the most.

Step 4 — Count it for seven days before you start. Tally the same outcome for one baseline week. Do not trust yourself to reconstruct it two months later.

Step 5 — Write your stop rule before day one. Decide what change would make continuing worth the money. A personal example might be: “If I am still waking four nights a week at my decision date, I stop and book an appointment.” That is your value threshold, not a universal medical definition of success.

Step 6 — Avoid changing five things at once. Starting a supplement, stopping alcohol, replacing bedding, and beginning a new sleep medication in the same week may help—but you will not know which change did what. Safety and clinician-directed treatment always outrank a clean self-experiment.

Step 7 — Use the right decision date. For a Complete formula, make a day-28 checkpoint because that is the earliest timing the brand advertises. For the targeted black-cohosh-and-soy formulas, day 60 is the manufacturer's stated minimum. Stop sooner for an adverse reaction, a new red flag, or clinician advice.

Step 8 — Obey the rule you wrote. You are allowed to quit. Finishing the bottle is not a moral achievement, and buying another one is not proof the first worked.

Printable tracker

What to record	Your entry
Exact Estroven formula
Active ingredients and dose
Date baseline week starts
One symptom number
Seven-day baseline total or average
First dose date
Day-28 checkpoint date
Day-60 decision date, if applicable
My prewritten continue/stop rule
New side effects or interaction concerns
Decision: continue, stop, or book care

A tracker cannot prove causation. It can stop a $20 experiment from turning into a year of “maybe.”

Is Estroven FDA approved—and what is the 2026 lawsuit about?

No. Estroven is a dietary supplement, so FDA does not approve it for safety or effectiveness before sale. Separately, a proposed class action involving Mood Boost and Stress Relief & Energy Boost was filed in federal court in July 2026. The complaint contains allegations, not findings, and it is not an FDA action or product recall.^[27][33][34]

What “not FDA approved” means here

FDA regulates dietary supplements under a different framework from drugs. Supplement manufacturers are responsible for evaluating safety and labeling before marketing, while FDA can act after a product reaches the market if it is adulterated or misbranded.^[27]

Structure/function claims and certain other supplement claims do not go through FDA preapproval. When those claims are used, the label must carry the DSHEA disclaimer explaining that FDA has not evaluated the claim and that the product is not intended to diagnose, treat, cure, or prevent disease.^[28]

Current Estroven product pages display that disclaimer. Read it next to the large efficacy language on the same page. That is not a technicality. It is the dividing line between an approved drug claim and a supplement claim the manufacturer is responsible for substantiating.

The lawsuit, plainly and with the correct case number

• Case: Arnold v. I-Health, Inc. et al.
• Assigned civil number: 2:26-cv-02634-DJC-SCR
• Initial miscellaneous filing number: 2:26-at-01282
• Court: U.S. District Court for the Eastern District of California
• Complaint filed: July 29, 2026
• Civil case assigned: July 30, 2026
• Defendants: i-Health, Inc. and DSM Nutritional Products, Inc.
• Products identified in the complaint: Estroven Mood Boost and Estroven Stress Relief & Energy Boost

The complaint alleges, among other things, that efficacy representations for the named formulas are misleading, that the products are promoted in a way that makes them unapproved new drugs, and that the DSHEA disclaimer is not presented as federal labeling rules require.^[34]

What this is not:

• It is not a recall.
• It is not an FDA warning letter.
• It is not a finding that the products are unsafe.
• It is not a judgment that the plaintiff's allegations are true.
• It does not name the Complete rhapontic-rhubarb formulas.

The public docket snapshot we reviewed listed the complaint and summons, not a merits ruling. Until a court rules or the parties resolve the case, the claims remain allegations.^[33]

One regulatory detail the complaint section needs in 2026

One allegation concerns whether the required disclaimer appears on every label panel carrying a structure/function claim. In December 2025, FDA said it was considering removing the regulatory “each panel” requirement and would exercise enforcement discretion on that specific placement issue in the meantime. FDA did not eliminate the underlying statutory disclaimer or the requirement to connect it to covered claims.^[29]

That context does not decide the lawsuit. It does mean “the disclaimer was not repeated on every panel” should not be presented as a settled current violation without acknowledging FDA's December 2025 enforcement position.

We are including the case because a reasonable buyer comparing the two named products would want to know it exists. We are not using an unresolved complaint as proof that either formula is ineffective or unlawful.

What does Estroven really cost for a fair comparison?

Current one-time manufacturer prices run from $13.99 to $34.99 per box. The more honest comparison is the cash needed to obtain at least 60 daily servings: $24.99 to $56.97 before tax and shipping. Cost per serving runs from about $0.42 for 60-count Sleep Cool or Mood Boost to about $0.88 for gummies.^[1]

Again: 60 servings is our normalized comparison. The Complete family advertises possible results in as little as 28 days; the five targeted formulas state a 60-day minimum.

The real cost table

Product	Published one-time price and count	Lowest current spend to obtain at least 60 servings	Servings purchased	Cost per serving
Sleep Cool	$13.99 / 30; $24.99 / 60	$24.99	60	$0.42
Mood Boost	$13.99 / 30; $24.99 / 60	$24.99	60	$0.42
Complete Multi-Symptom caplets	$19.99 / 28; $29.99 / 60	$29.99	60	$0.50
Complete + Ashwagandha	$34.99 / 60	$34.99	60	$0.58
Pre-Menopause	$18.99 / 30; $34.99 / 60	$34.99	60	$0.58
Weight Management	$18.99 / 30; $34.99 / 60	$34.99	60	$0.58
Complete Gummies	$26.48 / 30	$52.96	60	$0.88
Stress Relief & Energy Boost	$18.99 / 28	$56.97	84	$0.68

Verified September 2, 2026 from current manufacturer pages. Excludes tax, one-time-order shipping, retailer pricing, coupons, and subscription discounts. Totals are arithmetic based on one daily serving.

The Stress Relief box that does not add up

This is the finding that made us build the 60-serving column in the first place.

Stress Relief & Energy Boost comes in a 28-count box. The page also calls it a “30 Day Supply.” The directions say one caplet daily, and the brand says to allow a minimum of 60 days.^[7]

Do the arithmetic:

• One box: 28 servings.
• Two boxes: 56 servings—four short of 60.
• Three boxes: 84 servings for $56.97.

That makes it the highest cash outlay in the current line to clear 60 servings. It also carries 52 mg caffeine, 80 mg black cohosh, and one of the two formula names in the July 2026 complaint.

The gummy premium is about $140 a year at today's price

Sixty servings of Complete Gummies cost $52.96. Sixty Complete caplet servings cost $29.99. The difference is $22.97, or about 77%.

At one serving every day, using today's one-time prices and assuming the price does not change, the straight-line annual cost is about:

• $182 for Complete caplets.
• $322 for Complete Gummies.
• $140 more per year for the gummy form.

Those are labeled arithmetic estimates, not checkout quotes. They exclude tax, shipping, discounts, missed doses, and price changes.

Estroven's FAQ describes form as the key difference between the Complete caplet and gummy. The active panel supports the important part of that statement: both publish 4 mg ERr 731. The finished products are not literally identical; the gummy lists sugar and has different inactive ingredients.^[2][3]

If swallowing a caplet reliably stops you from taking it, the premium may earn its keep. If it does not, you are paying substantially more for delivery form and flavor, not a higher published dose of the menopause active.

Direct-order shipping, subscription, and returns

Direct-site term	What the current policy says	The practical effect
One-time shipping	Free shipping on orders over $30	The 60-count Complete at $29.99 misses the threshold by one cent; 60-count Sleep Cool and Mood Boost at $24.99 also sit below it.
Subscribe & Save	10% off, free shipping, skip or cancel	The discount changes cost, but a subscription can also turn an uncertain trial into automatic renewal. Set the stop rule first.[11]
Direct-site refund or replacement	Request within 30 days of receipt; shipping may be excluded and approval conditions apply	The return window may close before a targeted formula reaches the brand's 60-day minimum.[12]
Retailer purchase	Retailer's own terms apply	Keep the receipt and verify the count, expiration date, and current Supplement Facts panel before buying.

That 30-day-return-versus-60-day-trial mismatch is the policy detail that matters. A guarantee window is not the same thing as an efficacy window.

Spending $153 to $322 a year and still saying “maybe”? Use Find My HRT Path before the next renewal to see which clinician-led routes fit your symptoms, health history, insurance, state, and medication preferences.

What Estroven side effects and interactions matter most?

Safety depends on the box. Five formulas contain black cohosh and soy; Sleep Cool adds melatonin, Mood Boost adds ginkgo, Stress Relief adds caffeine, Complete + Ashwagandha adds ashwagandha, and two formulas add CQR-300. The most consequential questions are liver symptoms, hormone-sensitive cancer history, soy allergy, sedation, bleeding risk, thyroid or autoimmune disease, pregnancy, and medication interactions.^[18][19][20]

Start with the Supplement Facts panel, not the brand name. “Is Estroven safe?” has eight different ingredient answers.

The black cohosh liver question—both sides

The concern: NIH's LiverTox database describes reports of clinically apparent liver injury associated with products labeled as black cohosh, including severe cases. A United States Pharmacopeia review evaluated 30 reports and recommended a cautionary label advising people with liver disorders or signs of liver trouble to stop use and consult a healthcare practitioner.^[21][22]

The counterweight: A meta-analysis of five randomized, double-blind controlled trials involving 1,117 women found no evidence that a specific isopropanolic black cohosh extract adversely affected liver function over three to six months.^[23]

Both facts belong here. Controlled trials of one standardized extract did not reproduce liver toxicity. Case reports involving products labeled black cohosh still exist, and not every commercial formula uses the same extract, dose, authentication, or manufacturing process.

If you have liver disease, elevated liver enzymes, or take medication that can injure the liver, the five black-cohosh formulas are not where to improvise. If you develop dark urine, yellowing of the skin or eyes, unusual fatigue, persistent nausea, or abdominal pain while taking a black-cohosh product, stop and seek medical advice promptly.

If you have had breast or uterine cancer, read this before buying

NCCIH says it is uncertain whether black cohosh is safe for women who have had hormone-sensitive conditions such as breast or uterine cancer.^[18]

Black cohosh is in five current Estroven formulas. Those same five also contain soy isoflavones.

So the box you reached for because it says or implies “hormone-free” still raises a biological-activity question in exactly the history that makes you cautious. “Contains no hormones” describes the contents. It does not mean every plant compound is irrelevant to estrogen-responsive tissue.

Take the actual box to your oncology team before you start it. And hold onto this distinction: “Systemic hormone therapy is not right for me” and “there is no effective treatment I can discuss” are not the same sentence. Low-dose vaginal estrogen for genitourinary symptoms is a different decision from systemic therapy; guidance allows shared decision-making after nonhormonal options, with oncology involvement especially for people taking aromatase inhibitors.^[25]

No sales pitch in this paragraph. Your oncology team gets the call.

The soy question—and what the 35% number really means

Five formulas contain soy isoflavones. Two facts matter.

If you have a soy allergy, avoid those five formulas. Soy is one of the nine major food allergens identified in U.S. law. The three Complete formulas are listed as soy-free by the manufacturer.^[32][1]

Not everyone converts daidzein to S-equol. The Menopause Society statement says about 35% of North American women are equol producers, and it notes that a clinical test was not commercially available at the time of the statement.^[13]

That may help explain why soy responses vary. It does not mean a non-producer has zero chance of response, and it does not prove an equol producer will improve. Soy isoflavone activity is not a one-switch mechanism that lets us predict your result from that percentage.

Formula-by-formula interaction check

Ingredient	Which Estroven formulas publish it	What to raise with a pharmacist or prescriber
Black cohosh — 40 to 80 mg	Sleep Cool, Mood Boost, Stress Relief, Pre-Menopause, Weight Management	Liver disease or liver-affecting drugs; hormone-sensitive cancer history; all other medicines and supplements.
Soy isoflavones — 56 to 60 mg	The same five	Soy allergy; hormone-sensitive history; tamoxifen or other oncology treatment. Do not assume a food-level exposure and a concentrated supplement are interchangeable.
Melatonin — 2 mg	Sleep Cool	Other sedatives, alcohol, next-day drowsiness, driving, and operating machinery. The manufacturer directs bedtime use and warns against driving afterward.[5]
Ginkgo — 120 mg	Mood Boost	Anticoagulants, antiplatelets, bleeding disorders, seizure history, and upcoming surgery. NCCIH notes bleeding and drug-interaction concerns.[20]
Caffeine — 52 mg from green tea and yerba maté	Stress Relief & Energy Boost	Caffeine sensitivity, anxiety, palpitations, insomnia, migraine triggers, and total daily caffeine from every source.
Sensoril ashwagandha — 125 mg	Complete + Ashwagandha	Pregnancy or breastfeeding, thyroid disease, autoimmune disease, surgery, sedatives, anticonvulsants, immunosuppressants, blood-pressure and diabetes medicines, and rare liver-injury reports.[19]
Magnolia bark — 15 mg	Mood Boost, Stress Relief	Human interaction data are limited. Do not assume it is interaction-free; ask before combining it with sedating products.
CQR-300 / Cissus — 300 mg	Pre-Menopause, Weight Management	The 2023 Menopause Society statement did not evaluate it as a vasomotor-symptom treatment. Bring the panel when discussing weight or metabolic medicines.

Do not ask a pharmacist to check “Estroven.” Ask them to check the exact box and the exact panel against the complete medication and supplement list.

Does Estroven cause weight gain?

There is no reliable evidence establishing that Estroven causes weight gain across all eight formulas. One rhapontic-rhubarb trial reported no meaningful treatment-group weight difference over its study period, but that does not prove every formula is weight-neutral for every user or over long-term use.^[14]

Midlife weight change is common and has many possible causes. If weight is a deal-breaker for you, record it before starting, measure it consistently, and discuss a rapid or unexplained change with a clinician. A review anecdote can identify a question; it cannot prove causation.

Will Estroven help vaginal dryness, painful sex, or bladder symptoms?

Estroven Complete markets relief across a broad menopause symptom list that includes vaginal and urinary complaints. Those symptoms can be part of genitourinary syndrome of menopause (GSM), which commonly persists or worsens without targeted treatment. An oral supplement is not the guideline-established local treatment for GSM.^[2][24]

This is where we push back hardest.

Hot flashes often change over time. GSM commonly does not resolve on its own. Dryness, burning, painful sex, urinary urgency, recurrent urinary infections, and tissue fragility can persist and progress.^[24]

The 2025 AUA/SUFU/AUGS guideline recommends local low-dose vaginal estrogen for vulvovaginal discomfort and dyspareunia and recommends it to reduce recurrent urinary infections in appropriate perimenopausal and postmenopausal patients.^[24]

That does not mean every vaginal or urinary symptom is menopause, or that everyone should use estrogen. It means the symptom category has targeted assessment and treatment. If dryness, pain, bleeding with sex, urgency, or recurring infections are what actually sent you searching, do not burn 60 days waiting for an oral supplement to do a local treatment's job.

Low-dose vaginal estrogen is a cream, tablet, insert, or ring used locally. It is not interchangeable with systemic pills, patches, gels, or sprays, and its risk discussion is different. People with a history of estrogen-dependent breast cancer need shared decision-making; ACOG says low-dose vaginal estrogen may be considered after nonhormonal treatment has not adequately addressed symptoms, with additional coordination for people taking aromatase inhibitors.^[25]

• Vaginal estrogen: forms, evidence, safety, and how it differs from systemic HRT
• Current nonhormonal menopause treatment options
• Find the care route that fits your situation

Is Estroven the same as HRT—and can you take both?

No. Estroven is an over-the-counter dietary supplement, not hormone therapy. The manufacturer says its products contain no synthetic, animal-derived, or human-derived hormones. FDA-approved hormone therapy products are prescription medicines with approved ingredients, doses, indications, and labeling. Compounded hormone preparations are a third category and are not FDA-approved as finished products.^[1][30][31]

Three distinctions need to stay separate.

Estroven is not estrogen

The Complete formulas publish 4 mg of ERr 731 rhapontic rhubarb extract. Preclinical research describes selective activity at estrogen receptor beta, but the extract is not estrogen and has not been shown to be clinically equivalent to estradiol.^[15]

The five targeted formulas use black cohosh and soy isoflavones instead. Calling the whole line “plant estrogen” or “natural HRT” collapses different ingredients into a category they do not belong in.

Estroven is not FDA-approved hormone therapy

FDA-approved systemic hormone therapy includes prescription products containing estrogen, with a progestogen or another endometrial-protection strategy when needed for a person with a uterus. Product, route, dose, indication, age, time since menopause, and health history all change the benefit-risk discussion.

Estroven does not contain prescription estrogen, and taking it does not create the progestogen requirement that usually accompanies systemic estrogen therapy in a person with an intact uterus. That does not make the supplement risk-free or an HRT substitute.

Estroven is not compounded hormone therapy

Compounded hormone preparations are prescription products made by a compounding pharmacy for an identified patient. FDA does not approve compounded drugs as finished products and does not verify their safety, effectiveness, or quality before marketing in the way it does approved drugs.^[31]

Some patients need a compounded preparation when an FDA-approved option cannot meet a documented clinical need, such as an allergy to an inactive ingredient or an unavailable dosage form. That is not evidence that compounded products are safer, more natural, or equivalent to FDA-approved hormone therapy.

Supplements, compounded hormones, and FDA-approved hormone therapy are three separate categories. Anyone blending them into “basically the same thing” is removing information you need to choose safely.

Can you take Estroven with HRT?

Do not answer this from the brand name. The interaction question is different for ERr 731 alone, melatonin plus black cohosh and soy, ginkgo, caffeine, ashwagandha, and CQR-300.

Bring the exact box to the prescriber managing your hormone therapy and to your pharmacist. Do not add or stop a supplement without telling the person prescribing your medication. The answer may depend on your diagnosis, oncology history, liver function, other medicines, and the exact HRT route and ingredients.

What do real Estroven users say?

Estroven's own product pages contain strongly positive customer reviews, but manufacturer-hosted testimonials cannot establish efficacy or predict your result. We retained two short, attributable examples because they show what buyers are trying to solve—not because a quote can outrank a randomized trial or a guideline review.^[2][5]

A verified customer identified as Ferma wrote on the Complete Multi-Symptom page: “Hot flashes are barely there anymore.”

A verified customer identified as Nancy W. wrote on the Sleep Cool page: “not a single hot flash night or day.”

Those experiences may be sincere. They are also hosted on the manufacturer's sales pages, selected by individual experience, tied to different formulas, and not controlled comparisons. The result described in a testimonial may not be typical.

Why Estroven reviews conflict so much

Four structural reasons explain most of the contradiction:

1. Different products share one brand name. A review labeled “Estroven” may describe rhapontic rhubarb, black cohosh and soy, melatonin, ginkgo, caffeine, ashwagandha, or Cissus.
2. Formulas and packaging change while old reviews stay online. A review can remain attached to a listing after the panel, count, manufacturer, or seller changes.
3. Placebo groups improve substantially in hot-flash trials. The Menopause Society reports placebo improvement rates from 20% to 66%.^[13]
4. Menopause symptoms fluctuate without a supplement. Frequency and severity can change with cycle stage, season, stress, sleep, alcohol, illness, and time.

That is why “it worked for me” and “the evidence is not strong enough to recommend it” can both be true sentences.

The user-review question that matters more than stars

Do not ask, “Does Estroven have good reviews?” Ask:

• Which exact formula was reviewed?
• Was the reviewer verified, and by whom?
• Does the review describe the symptom you have?
• How long did the person take it?
• What else changed at the same time?
• Is the formula in the review still the formula on today's label?
• Did the person report a measured change or only a general feeling?

A review can give you vocabulary. It cannot give you your probability of benefit.

If your story is “my doctor told me to stop hormones, so I reached for a supplement,” do not assume the old conversation is the only conversation available now. Hormone therapy is still not appropriate for everyone, but guidance has evolved, routes differ, and evidence-based nonhormonal options exist. That does not mean your previous clinician was wrong about you. It means the question may be worth reopening with your current history on the table.

Estroven vs Amberen: does switching boxes solve the evidence problem?

Not really. The 2023 Menopause Society statement also did not recommend the ammonium-succinate formulation reviewed for Amberen, and it did not recommend pollen extract, S-equol, or the long list of other supplements it assessed for vasomotor symptoms. Moving to the next shelf brand does not automatically move you into stronger evidence.^[13]

Product or ingredient category	Ingredient assessed by the 2023 panel	Panel finding for vasomotor symptoms	What that means for the shopper
Estroven Complete	ERr 731 rhapontic rhubarb	Level II, not recommended	Positive studies exist, but trial limitations kept the society panel from recommending it.
Estroven targeted formulas	Black cohosh and soy extracts	Black cohosh Level I, not recommended; soy extracts Level II, not recommended	Changing the secondary ingredient does not repair the core evidence problem.
Amberen formulation reviewed	Ammonium succinate-based supplement	Level II, not recommended	The panel cited manufacturer-sponsored trials and insufficient independent evidence.
Relizen / Serelys category	Pollen extract	Level III, not recommended	A different botanical source is not automatically a stronger choice.
Equelle category	S-equol	Level II, not recommended	Bypassing the gut-conversion step did not produce a guideline recommendation.
Other supplements assessed	Red clover, maca, ginseng, dong quai, evening primrose, chasteberry, milk thistle, wild yam, omega-3s, vitamin E, and others	Not recommended	The problem is bigger than one brand.

Here is the category-level damaging admission:

If you have been working your way along the shelf, box by box, hoping the next supplement has the evidence the last one lacked, the panel already looked across the aisle. It did not recommend the category for hot flashes.

That does not forbid a bounded supplement trial. It does mean the next rational comparison is not automatically another bottle. It may be cognitive behavioral therapy, a nonhormonal prescription, hormone therapy if you are a candidate, targeted GSM treatment, or an in-person evaluation for a red flag.

When should you skip Estroven and talk to a clinician?

See a clinician instead of starting another supplement when symptoms are severe, bleeding occurs after menopause, a bleeding pattern changes unexpectedly, you have a hormone-sensitive cancer history or liver disease, pregnancy is possible, interactions are hard to judge, or a measured trial reaches its stop date without meaningful benefit. Postmenopausal bleeding should be evaluated, not self-treated.^[26]

Do not wait for the bottle to be finished

Seek prompt medical care for:

• Any bleeding after menopause.
• A sudden or unexplained change in bleeding pattern.
• Severe hot flashes or sleep disruption affecting safety, driving, work, or basic functioning.
• Yellow skin or eyes, dark urine, persistent nausea, unusual fatigue, or abdominal pain while taking a black-cohosh product.
• A new rash, swelling, breathing difficulty, or other possible allergic reaction.
• A new symptom that began after the supplement and feels severe, progressive, or frightening.

Call emergency services for chest pain, severe shortness of breath, fainting, one-sided weakness, sudden speech difficulty, or other signs of a medical emergency. Those are not supplement-comparison questions.

What to take to the appointment

Bring:

• The actual Estroven box or clear photos of every panel.
• Your complete medication and supplement list.
• The date you started and stopped.
• Your seven-day baseline and follow-up counts.
• A list of new symptoms or side effects.
• Your cancer, clot, liver, thyroid, seizure, migraine, and bleeding history where relevant.

Then ask:

1. Given my health history, am I a candidate for FDA-approved hormone therapy?
2. If not—or if I do not want it—which evidence-based nonhormonal options fit me?
3. Does anything in this exact supplement interact with my prescriptions or diagnoses?
4. Are my vaginal or urinary symptoms something we should evaluate and treat separately?
5. What outcome should change, and by when, so we can decide whether this plan is working?

When online care fits—and when it does not

The HRT Index evaluates provider models on five pillars, in this exact order: clinical legitimacy, care quality, medication fit, price transparency, and access.

Online care can be a practical route for many routine menopause questions, medication discussions, follow-up, and prescription management. It is not the right starting point for every person. Unexplained postmenopausal bleeding, symptoms needing a physical examination, an unstable medical condition, or an emergency belongs in the appropriate in-person setting.

We keep FDA-approved and compounded medications visibly separate in every comparison. A provider offering compounded hormones is not automatically inappropriate, but compounded finished products are not FDA-approved, and marketing them as safer, more natural, or equivalent to approved therapy is not supported by FDA's regulatory framework.^[31]

The supplement aisle no longer looks like your answer? Find My HRT Path uses your symptoms, state, insurance situation, medication preferences, and safety flags to route you to the provider model that fits—or tell you when online care is not the right starting point.

What did The HRT Index verify—and what did we not do?

This Estroven review is an independent documentation audit completed September 2, 2026. We verified the current U.S. product lineup, published active panels, direct prices, pack sizes, timing claims, direct-order policies, core medical evidence, safety sources, and the July 2026 federal filing. We did not take or laboratory-test the products, and the page is not medically reviewed by a clinician.

What we verified

• The eight current oral formulas on Estroven's U.S. product collection.
• Every published active ingredient and dose used in the formula matrix.
• Current one-time manufacturer prices and available pack counts.
• The 28-day Complete-family claim and the 60-day targeted-formula claim.
• The “30 Day Supply” label on a 28-count Stress Relief & Energy Boost page.
• The same published active panel and doses on Pre-Menopause and Weight Management.
• The 60-serving cash outlay and per-serving arithmetic for every formula.
• The current shipping threshold, subscription terms, and direct-order return window.
• The product-page footnotes behind sales, survey, and efficacy language.
• The Menopause Society sections on rhapontic rhubarb, black cohosh, soy, S-equol, Amberen, placebo response, and recommended alternatives.
• The pivotal ERr 731 randomized trial, 2024 meta-analysis, and June 2026 follow-up publication.
• FDA's dietary-supplement, disclaimer, approval, allergen, and compounding guidance.
• NCCIH, LiverTox, and peer-reviewed safety material used in the interaction section.
• The assigned federal case number, parties, filing dates, products identified in the complaint, and the public docket snapshot.
• The conflicting “Coming Soon” and discontinued or unavailable status shown for the Menopause Stage Indicator.

What we did not do

• We did not purchase, take, taste, or laboratory-test an Estroven product.
• We did not independently verify raw study data.
• We did not verify every inactive ingredient, tablet coating, supplier, batch, or manufacturing specification across the line.
• We did not treat manufacturer-hosted testimonials as proof.
• We did not invent a product score, a clinician review, a patient story, a medical credential, or a personal experience.
• We did not assume a retailer listing with an old photo or old review describes today's formula.

The HRT Index Verification Standard

The HRT Index Verification Standard is the documented process behind our decision pages. For provider reviews, that means checking clinical legitimacy, care quality, medication fit, price transparency, and access; keeping FDA-approved and compounded medication categories separate; verifying insurance, state availability, lab requirements, pricing, and cancellation terms; and dating every volatile fact.

For this product review, we applied the same discipline to the product lineup, labels, prices, policies, evidence, and legal status. We do not assign an invented per-product score. A conclusion has to be traceable to the source and useful after every commercial link is removed.

Prices, availability, policies, and the docket status should be rechecked monthly. The “Last verified” date should change only after the page has actually been re-audited.

Corrections and commercial disclosure

We have no affiliate, advertising, or commercial relationship with Estroven, i-Health, Inc., or dsm-firmenich. We received no free product. Some telehealth providers reached through this site's care-routing pages may have affiliate relationships with The HRT Index; those relationships do not determine the Estroven verdict or the order of the formula tables.

Found an error? Use the site's contact route and include the source. We will correct the page with a dated note.

Estroven FAQ

Which Estroven is best for hot flashes?

Within the Estroven line, Complete Multi-Symptom caplets in the 60-count are the cleanest formula to evaluate: ERr 731 rhapontic rhubarb 4 mg, no soy, no caffeine, and $0.50 per serving. That is an Estroven-specific editorial choice. The Menopause Society does not recommend rhapontic rhubarb for vasomotor symptoms.

Does Estroven really work?

Some studies and users report improvement, especially for ERr 731. The evidence is not strong enough for the 2023 Menopause Society panel to recommend rhapontic rhubarb, black cohosh, or soy extracts for hot flashes. A bounded, measured trial may help you decide whether one formula changes your symptom; reviews cannot predict it.

How long does Estroven take to work?

The three Complete formulas advertise results in as little as 28 days. Sleep Cool, Mood Boost, Stress Relief & Energy Boost, Pre-Menopause, and Weight Management say to allow a minimum of 60 days. Stop sooner for a suspected adverse reaction or clinician advice.

Is Estroven FDA approved?

No. Estroven products are dietary supplements. FDA does not approve dietary supplements for safety or effectiveness before they are sold. The manufacturer is responsible for safety and labeling, and FDA can take post-market action against adulterated or misbranded products.

Is Estroven the same as HRT?

No. Estroven contains botanical and other supplement ingredients, not prescription estrogen or progesterone. FDA-approved hormone therapy, compounded hormone preparations, and dietary supplements are three separate categories.

Does Estroven contain estrogen?

The manufacturer says no current Estroven product contains synthetic, animal-derived, or human-derived hormones. ERr 731 and soy isoflavones can interact with estrogen-receptor biology without being estrogen or becoming clinically equivalent to hormone therapy.

Do you need progesterone with Estroven?

Estroven does not contain prescription estrogen and does not create the progestogen requirement that generally applies when systemic estrogen is prescribed to a person with an intact uterus. That answer does not make the supplement interaction-free; bring the exact box to the clinician managing your medications.

Can you take Estroven with HRT?

Ask the prescriber and pharmacist who know your exact HRT product and complete medication list. The answer changes by Estroven formula because melatonin, ginkgo, caffeine, ashwagandha, black cohosh, soy, and CQR-300 raise different questions.

Can you take two Estroven products at once?

Do not stack them on your own. Estroven's Sleep Cool FAQ says not to combine Sleep Cool with a daytime Estroven product and says the products were developed for individual use. Combining formulas can duplicate black cohosh and soy or add sedating and stimulating ingredients together.

Which Estroven products contain soy?

Five formulas publish soy isoflavones: Sleep Cool, Mood Boost, Stress Relief & Energy Boost, Pre-Menopause, and Weight Management. The Complete caplet, Complete gummy, and Complete + Ashwagandha pages identify those products as soy-free.

Is Estroven safe after breast cancer?

Do not decide that from “hormone-free” marketing. NCCIH says the safety of black cohosh in people with hormone-sensitive conditions such as breast or uterine cancer is uncertain. Five Estroven formulas contain it. Take the exact box to your oncology team.

Does Estroven cause weight gain?

No reliable evidence establishes weight gain as an effect across the eight-formula line. A short ERr 731 trial did not show a meaningful treatment-group weight difference, but that cannot prove every formula is weight-neutral for every person. Track a consistent baseline if this concern would change your decision.

Is Estroven Weight Management different from Pre-Menopause?

Their current published active panels and doses match: black cohosh 40 mg, soy isoflavones 56 mg, and CQR-300 300 mg. We did not verify that all inactive ingredients and manufacturing details are identical, so the accurate statement is “same published active panel,” not “same finished product.”

Where is Estroven cheapest?

Retail prices change by seller, pack, coupon, and location. At the manufacturer on September 2, 2026, box prices ran from $13.99 to $34.99, while obtaining at least 60 servings ran from $24.99 to $56.97. Compare the final checkout total, serving count, expiration date, and current Supplement Facts panel—not the headline box price alone.

What is the Estroven lawsuit case number?

The assigned federal civil number is 2:26-cv-02634-DJC-SCR in the U.S. District Court for the Eastern District of California. The complaint was initially entered under miscellaneous number 2:26-at-01282. It identifies Mood Boost and Stress Relief & Energy Boost and contains unproven allegations; it is not an FDA action or recall.

Is the Estroven Menopause Stage Indicator available?

The official collection displayed “Coming Soon” while the product page was unavailable and tagged as discontinued when checked September 2, 2026. That conflict needs a manufacturer-site update. Do not treat an FSH home test as a diagnosis; the product page itself says to confirm results with a physician.

Still not sure which menopause care path is right for you?

You came here to decide whether one box on a shelf deserves your money. Whatever you decide, the bigger question underneath it—what is actually available given your symptoms, state, insurance, medical history, and medication preferences—deserves more than a supplement aisle can answer.

Find My HRT Path is free, takes about 90 seconds, does not require an email address, and flags when online care is not the right starting point.

→ Find the path that fits before my first consult

Sources

Product lineup, labels, prices, timing, and policies

¹ Estroven, All Products, product collection and current one-time prices, accessed September 2, 2026.

² Estroven, Complete Multi-Symptom Menopause Relief, current product page, Supplement Facts image, claims, timing, prices, and customer reviews, accessed September 2, 2026.

³ Estroven, Complete Menopause Relief Gummies, current product page, Supplement Facts image, timing, price, and FAQ, accessed September 2, 2026.

⁴ Estroven, Complete + Ashwagandha Menopause Relief, current product page, Supplement Facts image, timing, and price, accessed September 2, 2026.

⁵ Estroven, Menopause Relief Sleep Cool, current product page, Supplement Facts image, use directions, driving warning, individual-use FAQ, timing, prices, and customer review, accessed September 2, 2026.

⁶ Estroven, Menopause Relief Mood Boost, current product page, Supplement Facts image, timing, and prices, accessed September 2, 2026.

⁷ Estroven, Menopause Relief Stress Relief & Energy Boost, current product page, Supplement Facts image, 28-count pack, “30 Day Supply” text, timing, and price, accessed September 2, 2026.

⁸ Estroven, Pre-Menopause Relief, current product page, Supplement Facts image, timing, and prices, accessed September 2, 2026.

⁹ Estroven, Menopause Relief Weight Management, current product page, Supplement Facts image, timing, and prices, accessed September 2, 2026.

¹⁰ Estroven, Menopause Stage Indicator Test and All Products, conflicting product-status text and published test directions, accessed September 2, 2026.

¹¹ Estroven, Subscribe & Save, current discount, shipping, skip, and cancellation terms, accessed September 2, 2026.

¹² Estroven, Refund Policy, direct-order request window and conditions, accessed September 2, 2026.

Medical evidence and clinical guidance

¹³ The North American Menopause Society, The 2023 nonhormone therapy position statement, Menopause. 2023;30(6):573–590. PubMed record.

¹⁴ Heger M, et al. Efficacy and safety of a special extract of Rheum rhaponticum (ERr 731) in perimenopausal women. Menopause. 2006;13(5):744–759.

¹⁵ Wober J, et al. Activation of estrogen receptor-beta by a special extract of Rheum rhaponticum (ERr 731), its aglycones and structurally related compounds. Journal of Steroid Biochemistry and Molecular Biology. 2007.

¹⁶ Ghasemzadeh Rahbardar M, et al. Efficacy evaluation of standardized Rheum rhaponticum extract in menopausal women: a systematic review and meta-analysis. Journal of Biomedical Research. 2024.

¹⁷ Tuexen Y, et al. Menopausal symptom relief and improvement in quality of life with Rheum rhaponticum extract in perimenopausal women. Frontiers in Pharmacology. 2026. PubMed record.

¹⁸ National Center for Complementary and Integrative Health, Menopausal Symptoms: In Depth, black cohosh efficacy, liver, interaction, and hormone-sensitive-condition discussion.

¹⁹ National Center for Complementary and Integrative Health, Ashwagandha, pregnancy, thyroid, autoimmune, surgery, interaction, sedation, and liver safety information.

²⁰ National Center for Complementary and Integrative Health, Ginkgo, bleeding and drug-interaction safety information.

²¹ National Institute of Diabetes and Digestive and Kidney Diseases, Black Cohosh, LiverTox.

²² Mahady GB, et al. United States Pharmacopeia review of the black cohosh case reports of hepatotoxicity. Menopause. 2008;15(4 Pt 1):628–638.

²³ Naser B, et al. Suspected black cohosh hepatotoxicity: no evidence by meta-analysis of randomized controlled clinical trials for isopropanolic black cohosh extract. Menopause. 2011.

²⁴ American Urological Association, Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction, and American Urogynecologic Society, Genitourinary Syndrome of Menopause Guideline, 2025.

²⁵ American College of Obstetricians and Gynecologists, Treatment of Urogenital Symptoms in Individuals With a History of Estrogen-dependent Breast Cancer, Clinical Consensus, 2021.

²⁶ American College of Obstetricians and Gynecologists, The Role of Transvaginal Ultrasonography in Evaluating the Endometrium of Women With Postmenopausal Bleeding, Committee Opinion.

FDA and legal sources

²⁷ U.S. Food and Drug Administration, Questions and Answers on Dietary Supplements, premarket and post-market responsibilities.

²⁸ U.S. Food and Drug Administration, Structure/Function Claims, dietary-supplement claim and disclaimer framework.

²⁹ U.S. Food and Drug Administration, FDA Announces Intent to Initiate Rulemaking to Remove Requirement for Duplicate Dietary Supplement Disclaimers on Product Labels, December 9, 2025.

³⁰ U.S. Food and Drug Administration, Is It Really “FDA Approved”?, distinction between approved drugs and dietary supplements.

³¹ U.S. Food and Drug Administration, Compounding and the FDA: Questions and Answers, status and oversight of compounded drugs.

³² U.S. Food and Drug Administration, Food Allergies, nine major food allergens, including soy.

³³ Arnold v. I-Health, Inc. et al., assigned case No. 2:26-cv-02634-DJC-SCR, U.S. District Court for the Eastern District of California. Public docket summary, reviewed September 2, 2026.

³⁴ Arnold v. I-Health, Inc. et al., Complaint, filed July 29, 2026. Allegations remain unproven unless established by a court or agreement.

---

This page is educational and is not medical advice. It has not been medically reviewed by a clinician. Talk with a qualified healthcare professional before starting or stopping a supplement or medication, and use urgent or emergency care when symptoms require it.